Altered spermidine/spermine N1-acetyltransferase activity as a mechanism of cellular resistance to

D E McCloskey1, A E Pegg

  • 1Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA. dem15@psu.edu

Insights

Researchers developed a drug-resistant cell line to study anticancer drugs. They found a mutation in the spermidine/spermine N(1)-acetyltransferase (SSAT) enzyme, proving it

Area of Science:

  • Cell biology
  • Molecular pharmacology
  • Cancer research

Background:

  • Bis(ethyl)polyamine analogues exhibit antiproliferative effects.
  • Understanding resistance mechanisms is crucial for drug development.

Purpose of the Study:

  • To develop a model system for investigating resistance to bis(ethyl)polyamine analogues.
  • To elucidate the role of spermidine/spermine N(1)-acetyltransferase (SSAT) in analogue resistance.

Main Methods:

  • Selection of a resistant Chinese hamster ovary cell line (C55.7Res) to N(1), N(12)-bis(ethyl)spermine.
  • Analysis of polyamine transport, SSAT activity, mRNA, and protein levels.
  • Sequencing of SSAT cDNA to identify mutations.
  • Complementation studies by expressing wild-type SSAT in resistant cells.

Main Results:

  • C55.7Res cells showed stable, heritable resistance to bis(ethyl)polyamines, independent of transport or multi-drug resistance.
  • Basal SSAT activity was decreased in C55.7Res cells, with no induction upon analogue exposure.
  • No SSAT protein was detected in resistant cells, despite unchanged mRNA levels.
  • A point mutation (L156F) in SSAT cDNA was identified in C55.7Res cells.
  • Restoration of wild-type SSAT activity re-sensitized cells to the analogues.

Conclusions:

  • SSAT enzyme activity is a critical target for the antiproliferative action of bis(ethyl)polyamine analogues.
  • A mutation in SSAT can confer resistance to these compounds.
  • The C55.7Res cell line is a valuable tool for studying SSAT-mediated drug resistance mechanisms.

Related Concept Videos

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...